Annual Current Assets
$58.91 M
+$36.81 M+166.58%
31 December 2023
Summary:
SAB Biotherapeutics annual total current assets is currently $58.91 million, with the most recent change of +$36.81 million (+166.58%) on 31 December 2023. During the last 3 years, it has risen by +$24.45 million (+70.97%). SABS annual current assets is now at all-time high.SABS Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$32.54 M
-$7.04 M-17.80%
30 September 2024
Summary:
SAB Biotherapeutics quarterly total current assets is currently $32.54 million, with the most recent change of -$7.04 million (-17.80%) on 30 September 2024. Over the past year, it has increased by +$29.41 million (+940.29%). SABS quarterly current assets is now -44.77% below its all-time high of $58.91 million, reached on 31 December 2023.SABS Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +166.6% | +940.3% |
| 3 y3 years | +71.0% | +4122.3% |
| 5 y5 years | - | - |
SABS Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +166.6% | -44.8% | +4122.3% |
| 5 y | 5 years | at high | +534.2% | -44.8% | +4122.3% |
| alltime | all time | at high | +534.2% | -44.8% | +4122.3% |
SAB Biotherapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $32.54 M(-17.8%) |
| June 2024 | - | $39.58 M(-15.7%) |
| Mar 2024 | - | $46.95 M(-20.3%) |
| Dec 2023 | $25.03 M(-13.1%) | $58.91 M(+1783.4%) |
| Sept 2023 | - | $3.13 M(-65.3%) |
| June 2023 | - | $9.01 M(-40.1%) |
| Mar 2023 | - | $15.03 M(-32.0%) |
| Dec 2022 | $28.81 M | $22.10 M(-0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $22.18 M(-20.1%) |
| June 2022 | - | $27.75 M(-23.3%) |
| Mar 2022 | - | $36.17 M(-27.9%) |
| Dec 2021 | $30.95 M(+40.1%) | $50.19 M(+6413.4%) |
| Sept 2021 | - | $770.60 K(-97.2%) |
| June 2021 | - | $27.77 M(-19.4%) |
| Dec 2020 | $22.08 M(+153.4%) | $34.45 M |
| Dec 2019 | $8.71 M | - |
FAQ
- What is SAB Biotherapeutics annual total current assets?
- What is the all time high annual current assets for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual current assets year-on-year change?
- What is SAB Biotherapeutics quarterly total current assets?
- What is the all time high quarterly current assets for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly current assets year-on-year change?
What is SAB Biotherapeutics annual total current assets?
The current annual current assets of SABS is $58.91 M
What is the all time high annual current assets for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual total current assets is $58.91 M
What is SAB Biotherapeutics annual current assets year-on-year change?
Over the past year, SABS annual total current assets has changed by +$36.81 M (+166.58%)
What is SAB Biotherapeutics quarterly total current assets?
The current quarterly current assets of SABS is $32.54 M
What is the all time high quarterly current assets for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly total current assets is $58.91 M
What is SAB Biotherapeutics quarterly current assets year-on-year change?
Over the past year, SABS quarterly total current assets has changed by +$29.41 M (+940.29%)